Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
Weight Loss· Medically reviewed

GLP-1 hair loss (Ozempic, Wegovy, Zepbound): why it happens and what helps

Hair shedding on GLP-1 medications is real, common, and usually temporary. The driver is rapid weight loss triggering telogen effluvium, not the drug itself. Here's how to tell which type of hair loss you have, what helps, and when to escalate to a dermatologist.

3 min readUpdated

0.0%
Wegovy STEP-1 hair-loss rate vs 1.4% placebo
0-4 mo
typical lag between weight loss start and shedding
0-9 mo
usual telogen effluvium resolution timeline
0.0g/kg
minimum protein for hair recovery

What the trials actually show

In the STEP-1 trial (semaglutide for weight management), hair loss was reported as an adverse event in 3.0% of semaglutide-treated participants vs 1.4% of placebo. In the SURMOUNT-1 trial (tirzepatide), the imbalance was similar. The mechanism is almost certainly indirect: a sudden, sustained calorie deficit plus significant weight loss triggers telogen effluvium, a temporary shift of hair follicles into the resting phase.

Telogen effluvium is not the same as androgenetic alopecia (male/female pattern baldness) or alopecia areata. It is a diffuse shedding from the entire scalp, not a focal pattern. The hair follicle itself isn't destroyed — it's paused. When the trigger resolves, the follicle restarts. That's why most GLP-1-related shedding resolves within 6-9 months of weight stabilizing.

How to tell which type of hair loss you have

Telogen effluvium signs: diffuse shedding across the entire scalp, more hair in the shower drain and on the pillow, often noticed 2-4 months after starting the GLP-1 or after a significant weight loss milestone, no scalp irritation, hairline intact, density reduced uniformly.

Androgenetic alopecia signs: gradual thinning at the crown or hairline (men: receding temples; women: midline part widening), often started years before the GLP-1, family history of pattern hair loss, no acute shedding episode.

Alopecia areata signs: distinct round or oval patches of complete hair loss with no underlying scalp irritation. Not related to GLP-1s.

Nutritional deficiency hair loss: shedding accompanied by other signs — nail brittleness, fatigue, mouth sores — suggests iron, vitamin D, B12, or zinc deficiency. Worth testing if shedding is severe or prolonged.

If unsure, a dermatologist can confirm telogen effluvium with a pull test (gentle traction extracts >3-5 hairs in active shedding) and rule out the others.

What actually helps

Slow your rate of weight loss. Aiming for 0.5-0.75% of body weight per week (instead of 1-2%) gives the hair cycle time to adapt. This often means staying longer on a lower GLP-1 dose. Discuss with your prescriber.

Protein and micronutrients. Aim for 1.2-1.6 g protein per kg body weight daily — hair shaft is keratin. Ensure iron (ferritin >50 ng/mL is the dermatology target), vitamin D (>30 ng/mL), zinc, and B12 are adequate. Blood work if shedding is prolonged.

Minoxidil (over-the-counter, Rogaine + generics). 5% topical once daily can shorten telogen effluvium recovery and increase hair-shaft thickness. Visible effect at 3-6 months. Independent of GLP-1.

Time. Most GLP-1-associated telogen effluvium resolves within 6-9 months of weight stabilizing without active intervention. Reassurance is part of the treatment.

When to escalate to a dermatologist

Shedding lasts >9 months after weight stabilization, you see clearly patterned thinning (crown, hairline, temples) rather than diffuse, scalp is itchy/painful/inflamed, personal or family history of autoimmune disease, or shedding causes emotional distress regardless of severity. Any of these is a reason to escalate.

Dermatologists can perform a pull test, scalp biopsy if needed, and offer prescription-strength minoxidil (oral, 0.625-2.5 mg/day) which has stronger evidence for telogen effluvium than topical alone. They can also rule out harder-to-spot causes (early female pattern hair loss, scarring alopecia) that telogen effluvium can mask.

Sources

Primary sources cited above. FDA labeling, peer-reviewed trials, and specialty-society guidelines only.

  1. STEP-1 Trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity · New England Journal of Medicine, 2021 · PMID 33616314
  2. Wegovy (semaglutide) Prescribing Information — Adverse Reactions · U.S. Food and Drug Administration, 2024
  3. Telogen effluvium: a review · Journal of the American Academy of Dermatology, 2019
  4. SURMOUNT-1 Trial: Tirzepatide Once Weekly for the Treatment of Obesity · New England Journal of Medicine, 2022 · PMID 35658024

People also ask

  • Is hair loss from Ozempic permanent?

    Almost never. GLP-1-associated hair loss is overwhelmingly telogen effluvium — a temporary shift of follicles into resting phase. The follicle isn't destroyed; it restarts when the trigger (rapid weight loss) resolves. Most people see hair density recover within 6-9 months of weight stabilizing.

  • When does hair loss usually start on Ozempic or Wegovy?

    Typically 2-4 months after starting the medication, or 2-4 months after a major weight loss milestone. Hair follicles take that long to enter and exit the resting phase. This lag is why people often don't connect the shedding to weight loss until they look at the timeline.

  • Does taking biotin help with GLP-1 hair loss?

    Biotin specifically helps only in true biotin deficiency, which is rare in adults eating a normal diet. For telogen effluvium tied to GLP-1 weight loss, biotin has minimal effect. Better evidence: adequate protein (1.2-1.6 g/kg), iron, vitamin D, and topical minoxidil.

  • Should I stop my GLP-1 if I'm losing hair?

    Usually not. Stopping the GLP-1 typically leads to weight regain, which reverses the metabolic and cardiovascular benefits that were the reason for treatment. The better approach is slowing the rate of weight loss, increasing protein, and using minoxidil if appropriate. Discuss any change with your prescriber.

  • Can I use minoxidil while on Ozempic, Wegovy, Zepbound, or Mounjaro?

    Yes. Minoxidil (topical or low-dose oral) does not interact with GLP-1 medications. The combination is commonly used by patients with concurrent telogen effluvium and pattern hair loss. Confirm with your prescriber before adding oral minoxidil if you have cardiovascular conditions.

Related reads

Share:
We may earn a commission when you click links to partners. Affiliate disclosure.